Risk factors for ribavirin treatment failure in Asian organ transplant recipients with chronic hepatitis E infection

doi:10.4254/wjh.v11.i6.553

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8122)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

297

WORD

183

HTML

2144

Figures (1-2)

244

Tables (1-2)

220

Sum=3088

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

1531

Download

1337

Sum=2868

Publishing Process of This Article

Item

Count

Browse

893

Download

1273

Sum=2166

Jun 27, 2019 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Hepatol. Jun 27, 2019; 11(6): 553-561
Published online Jun 27, 2019. doi: 10.4254/wjh.v11.i6.553

Open in New Tab Full Size Figure Download Figure

Figure 1 Outcomes of ribavirin therapy in transplant recipients with hepatitis E virus infection. HEV: Hepatitis E virus.

Open in New Tab Full Size Figure Download Figure

Figure 2 Hepatitis E virus concentration during ribavirin therapy. BL: Baseline; EOT: End of treatment.

Citation: Low EXS, Tripon E, Lim K, Tan PS, Low HC, Dan YY, Lee YM, Muthiah M, Loo WM, Koh CJ, Phyo WW, Pang J, Lim SG, Lee GH. Risk factors for ribavirin treatment failure in Asian organ transplant recipients with chronic hepatitis E infection. World J Hepatol 2019; 11(6): 553-561
URL: https://www.wjgnet.com/1948-5182/full/v11/i6/553.htm
DOI: https://dx.doi.org/10.4254/wjh.v11.i6.553